Skye Bioscience SKYE
NASDAQ SKYE
$1.60 -0.01 (-0.62%)
As of: Oct 1, 2026 · 3:59 PM EDT

Skye Bioscience (SKYE) Return on Equity [ROE] (2013 - 2026)

Updated

Skye Bioscience (SKYE) posted Return on Equity [ROE] of -1186.04% for Q2 2026, down 1103.70 percentage points from -82.34% a year earlier and down 791.14 percentage points from the prior quarter.

Analysis

Skye Bioscience (SKYE) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2025, Skye Bioscience's Return on Equity [ROE] came in at -126.85%, down 46.37 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +1186.81 percentage points (FY2020 to FY2025).
  • In prior years, Skye Bioscience's Return on Equity [ROE] was -80.48% in FY2024, -1364.20% in FY2022 (-1094.30 pp) and -269.90% in FY2021 (+1043.75 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2014.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -284.58 percentage points over the last six quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 451.95 percentage points; the weakest was Q2 2026, with a drop of 1103.70 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -394.90% (Q1 2026), -211.59% (Q4 2025) and -133.91% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Skye Bioscience 7.07 Mn 7.07 Mn - -1,186.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,186.04%
Mar 31, 2026 -394.90%
Dec 31, 2025 -211.59%
Sep 30, 2025 -133.91%
Jun 30, 2025 -82.34%
Mar 31, 2025 -51.26%
Dec 31, 2024 -36.91%
Sep 30, 2024 -28.59%
Jun 30, 2024 -55.76%
Mar 31, 2024 -97.71%
Jun 30, 2022 -808.63%
Mar 31, 2022 -212.85%
Dec 31, 2021 -120.63%
Sep 30, 2021 -142.59%
Jun 30, 2021 -294.05%
Mar 31, 2021 -435.55%
Dec 31, 2020 -572.58%
Dec 31, 2014 -1,668.89%
Sep 30, 2014 -234.44%
Oct 31, 2013 -5.39%
API Access

Skye Bioscience Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SKYE&period=max&api_key=YOUR_API_KEY